Literature DB >> 9610701

The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.

S J DiBiase1, L T Komarnicky, G F Schwartz, Y Xie, C M Mansfield.   

Abstract

BACKGROUND: There are conflicting reports regarding whether focally positive surgical margins influence tumor control in breast-conservation therapy. The authors have evaluated the relation between positive surgical margins on tumor control and whether the number of positive margins affects tumor control in patients undergoing reexcision lumpectomy.
METHODS: From 1978 to 1994, 453 American Joint Committee on Cancer Stage I/II breast carcinoma patients were treated at Thomas Jefferson University Hospital with breast conservation therapy. Patients underwent excisional biopsy and margin sampling with shaved biopsies of the tumor cavity. The entire breast received 45 grays (Gy) with a 20-Gy iridium-192 implant or an electron boost. Eighty-six patients had microscopically positive margins (19%), and the remainder had confirmed negative margins. The median follow-up time was 45 months.
RESULTS: Local tumor control rates for patients with negative margins at 5 and 10 years were 94% and 87%, respectively, compared with 86% and 69%, respectively, for those patients with positive margins (P=0.005). The disease free survival rates for the negative margin group at 5 and 10 years were 91% and 82%, respectively, compared with 76% and 71%, respectively, for the positive margin group (P=0.001). Overall survival rates for patients with negative margins at 5 and 10 years were 95% and 84%, respectively, compared with 87% and 78%, respectively, for those with positive margins (P=0.047). When comparing the negative margin group with the one positive margin group, there was no significant difference in local tumor control (P=0.12). However, women with two or more positive margins had an inferior local tumor control compared with those women with negative margins (P=0.002).
CONCLUSIONS: Patients with positive margins have a higher risk for local failure and worse survival when undergoing breast conservation therapy. Inferior local tumor control was noted in those patients with two or more positive margins.

Entities:  

Mesh:

Year:  1998        PMID: 9610701

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey.

Authors:  Alphonse Taghian; Majid Mohiuddin; Reshma Jagsi; Saveli Goldberg; Elizabeth Ceilley; Simon Powell
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

Review 2.  Recent developments in breast-conserving surgery for breast cancer patients.

Authors:  F Fitzal; O Riedl; R Jakesz
Journal:  Langenbecks Arch Surg       Date:  2008-09-10       Impact factor: 3.445

Review 3.  The role of boost irradiation in the conservative treatment of stage I-II breast cancer.

Authors:  C Polgár; J Fodor; T Major; Z Orosz; G Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 4.  Breast cancer local therapy: what is its effect on mortality?

Authors:  John R Benson; Katy A T Teo
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

5.  Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer.

Authors:  M M Moore; L A Whitney; L Cerilli; J Z Imbrie; M Bunch; V B Simpson; J B Hanks
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

6.  Technical factors, surgeon case volume and positive margin rates after breast conservation surgery for early-stage breast cancer.

Authors:  Peter J Lovrics; Sylvie D Cornacchi; Forough Farrokhyar; Anna Garnett; Vicky Chen; Slobodan Franic; Marko Simunovic
Journal:  Can J Surg       Date:  2010-10       Impact factor: 2.089

7.  Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

Authors:  Heather A Jones; Ninja Antonini; Augustinus A M Hart; Johannes L Peterse; Jean-Claude Horiot; Françoise Collin; Philip M Poortmans; S Bing Oei; Laurence Collette; Henk Struikmans; Walter F Van den Bogaert; Alain Fourquet; Jos J Jager; Dominic A X Schinagl; Carla C Wárlám-Rodenhuis; Harry Bartelink
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

8.  Breast cancer abutting the pectoralis major muscle on breast MRI: what are the clinical implications?

Authors:  Kelly S Myers; Erica Stern; Emily B Ambinder; Eniola T Oluyemi
Journal:  Br J Radiol       Date:  2021-01-05       Impact factor: 3.039

9.  A colorful approach towards developing new nano-based imaging contrast agents for improved cancer detection.

Authors:  Helen R Salinas; Dominie L Miyasato; Olga E Eremina; Rodolfo Perez; Karen L Gonzalez; Alexander T Czaja; Sean Burkitt; Arjun Aron; Augusta Fernando; Lauro S Ojeda; Kimberly N Larson; Ahmed W Mohamed; Jos L Campbell; Beth A Goins; Cristina Zavaleta
Journal:  Biomater Sci       Date:  2020-08-19       Impact factor: 6.843

10.  Factors affecting surgical margin positivity in invasive ductal breast cancer patients who underwent breast-conserving surgery after preoperative core biopsy diagnosis.

Authors:  Bulent Koca; Bekir Kuru; Savas Yuruker; Barıs Gokgul; Necati Ozen
Journal:  J Korean Surg Soc       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.